Comparison of the effectiveness of four SARS-COV-2 v accines in Nuevo Leon, Mexico: A test-negative control studyOriginal Article Published on 2023-03-152024-09-05 Journal: Atención Primaria [Category] update2024, [키워드] Ad5-nCoV BNT162b2 ChAdOx1 CoronaVac COVID-19 vaccines Effectiveness eficácia Vacunas para COVID-19 [DOI] 10.1016/j.aprim.2023.102606 PMC 바로가기 [Article Type] Original Article
Justificativa e Desenho do Ensaio Clínico Randomizado COVID-19 Outpatient Prevention Evaluation (COPE – Coalition V): Hidroxicloroquina vs. Placebo em Pacientes Não HospitalizadosRandomized Controlled Trial Published on 2022-02-142022-10-04 Journal: Arquivos Brasileiros de Cardiologia [Category] COVID19(2023년), Fulltext, SARS, 임상, [키워드] A p-value analyses assigned benefit blinded Care chronic obstructive clinical clinical setting Coalition COPE coronavirus disease COVID-19 criteria desfecho primário diabete double-blind Effectiveness eficácia Ensaio Clínico Controlado Aleatório evaluate Evidence HCQ Hidroxicloroquina Hospitalization Hydroxychloroquine hypothesis test independent individuals with COVID-19 intention-to-treat principle knowledge largest trial lung matching placebo Mild symptom multicêntrico obesity objective outcome Outpatient patients Placebo placebo-controlled clinical trial Pragmatic pragmático Prevent prevention primary efficacy endpoint Primary outcome pulmonary disease question randomizado randomization Randomized Randomized controlled trial randomized study Result risk factor SARS-CoV-2 seeking specific treatment statistically significant symptom onset therapeutic option treatment groups two-sided with COVID-19 [DOI] 10.36660/abc.20210832 PMC 바로가기 [Article Type] Randomized Controlled Trial
Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary resultsReview Published on 2021-04-092022-10-31 Journal: Einstein [Category] COVID-19, MERS, SARS, [키워드] adverse events applied approach article base Betacoronavírus Betacoronavirus clinical trial combater conditions convalescent plasma Convalescent plasma therapy Coronavirus infections COVID-19 COVID-19 patients Critical case Critically ill patient database decrease disease drugs Efficacy effort eficácia Europe evaluate Evidence highlight Hospitalized hospitalized patients immunization Immunization, passive Imunização Imunização passiva Infecções por coronavírus Intervention less life-threatening Mortality MOST multicenter nCOV-2019 North America Oceania outcome pacientes com COVID-19 Pacientes hospitalizados Patient patients with COVID-19 performed Placebo plasma Plasma convalescente plasma exchange protocol reported SARS-CoV-2 severe disease Standard therapy the SARS-CoV-2 therapy [DOI] 10.31744/einstein_journal/2021RW6186 PMC 바로가기 [Article Type] Review
[Assessment of the MF59-adjuvanted pandemic influenza A/H1N1 vaccine. Systematic review of literature]Review Published on 2013-10-012023-06-24 Journal: An Pediatr (Barc) [Category] 신종인플루엔자, [키워드] Efficacy eficácia Influenza A virus H1N1 subtype Revisión sistemática Safety Seguridad systematic review Vacuna pandémica A/H1N1. [DOI] 10.1016/j.anpedi.2013.01.022 [Article Type] Review